[{"address1": "Times Square Tower", "address2": "Suite 2503 7 Times Square", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "646 200 5278", "website": "https://www.sellaslifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Angelos M. Stergiou M.D., ScD h.c.", "age": 48, "title": "Founder, President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 904243, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Thomas Burns CPA", "age": 39, "title": "Senior VP & CFO", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 505158, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy E. Yeung", "title": "VP of Legal Affairs, Head of Compliance & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dragan  Cicic M.D., MBA", "age": 61, "title": "Senior Vice President of Clinical Development", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 466430, "exercisedValue": 0, "unexercisedValue": 55739}, {"maxAge": 1, "name": "Mr. Andrew  Elnatan", "title": "Senior VP of Regulatory Affairs, CMC & Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.19, "open": 1.19, "dayLow": 1.17, "dayHigh": 1.22, "regularMarketPreviousClose": 1.19, "regularMarketOpen": 1.19, "regularMarketDayLow": 1.17, "regularMarketDayHigh": 1.22, "payoutRatio": 0.0, "beta": 2.435, "forwardPE": -2.767442, "volume": 653521, "regularMarketVolume": 653521, "averageVolume": 2781411, "averageVolume10days": 1041300, "averageDailyVolume10Day": 1041300, "bid": 1.19, "ask": 1.51, "bidSize": 1, "askSize": 2, "marketCap": 93512584, "fiftyTwoWeekLow": 0.77, "fiftyTwoWeekHigh": 1.84, "fiftyDayAverage": 1.1688, "twoHundredDayAverage": 1.2073, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 63299556, "profitMargins": 0.0, "floatShares": 70097636, "sharesOutstanding": 78582000, "sharesShort": 8652314, "sharesShortPriorMonth": 8999899, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.1101, "heldPercentInsiders": 0.00166, "heldPercentInstitutions": 0.085360005, "shortRatio": 1.75, "shortPercentOfFloat": 0.1103, "impliedSharesOutstanding": 78582000, "bookValue": 0.247, "priceToBook": 4.8178144, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -32280000, "trailingEps": -0.67, "forwardEps": -0.43, "lastSplitFactor": "1:50", "lastSplitDate": 1573171200, "52WeekChange": -0.125, "SandP52WeekChange": 0.12744582, "quoteType": "EQUITY", "currentPrice": 1.19, "targetHighPrice": 7.5, "targetLowPrice": 4.0, "targetMeanPrice": 5.83333, "targetMedianPrice": 6.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 21031000, "totalCashPerShare": 0.299, "totalDebt": 576000, "quickRatio": 1.982, "currentRatio": 2.265, "debtToEquity": 3.624, "returnOnAssets": -1.14452, "returnOnEquity": -5.35102, "freeCashflow": -21813000, "operatingCashflow": -33074000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "longName": "SELLAS Life Sciences Group, Inc.", "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.19, "shortName": "SELLAS Life Sciences Group, Inc", "corporateActions": [], "postMarketTime": 1741394196, "regularMarketTime": 1741381201, "exchange": "NCM", "messageBoardId": "finmb_262231850", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1205328600000, "postMarketChangePercent": 1.68067, "postMarketPrice": 1.21, "postMarketChange": 0.02, "regularMarketChange": 0.0, "regularMarketDayRange": "1.17 - 1.22", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2781411, "fiftyTwoWeekLowChange": 0.42000008, "fiftyTwoWeekLowChangePercent": 0.5454547, "fiftyTwoWeekRange": "0.77 - 1.84", "fiftyTwoWeekHighChange": -0.65, "fiftyTwoWeekHighChangePercent": -0.35326084, "fiftyTwoWeekChangePercent": -12.5, "dividendDate": 1573171200, "earningsTimestampStart": 1742986740, "earningsTimestampEnd": 1743422400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.67, "epsForward": -0.43, "epsCurrentYear": -0.53667, "priceEpsCurrentYear": -2.2173774, "fiftyDayAverageChange": 0.02120006, "fiftyDayAverageChangePercent": 0.018138314, "twoHundredDayAverageChange": -0.01729989, "twoHundredDayAverageChangePercent": -0.0143294055, "marketState": "CLOSED", "displayName": "SELLAS Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]